Advertisement
News
Advertisement

CanCHEW Bio-Technologies, a Medical Marijuana Inc. Product, Dr. George Anastassov Appeared on Small Cap Voice Internet Radio Program To Discuss The CanCHEW Advantage

Wed, 08/08/2012 - 11:50am
Bio-Medicine.Org

SAN DIEGO, Aug. 8, 2012 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA) a leading hemp industry innovator, is pleased to announce that Company Director of CanChew Biotechnologies Inc. Dr George E. Anastassov has recently appeared on Small Cap Voice's internet radio network. 

Dr. Anastassov Interview Archived

The interview, conducted by Small Cap Voice internet radio host, Stuart T. Smith gave a good insight into the history of CanChew Biotechnologies and Dr. Anastassov's participation in the development of the revolutionary new product.  CanChew's new high concentration hemp based CBD-infused chewing gum is expected for soft release on September 15th in United States, with international markets to soon follow suit. 

The interview can be found via the following link: Interview

Initially being released on the over-the-counter market as a health and wellness product, CanChew gum is undergoing clinical development in the European Union for pain relief, relief for muscular spasticity, particularly in MS patients as well as relief from Nausea, specifically from chemotherapy.  The key active ingredient, the hemp-based CBD-infused essential oil is made available by Medical Marijuana Inc and their state-of-the-art extraction technology. 

During the interview, Dr. Anastassov touched on some of the challenges facing present day prescription pain medications and the need, especially in Europe, for safe but effective pain relief options and how the CanChew advantages aims to bridge that gap. 

About CanCHEW

CanChew® is a unique, socially acceptab
'/>"/>

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading